Accelerate Diagnostics Inc Anno IPO
Cos'è Anno IPO di Accelerate Diagnostics Inc?
Anno IPO di Accelerate Diagnostics Inc è 1996
Qual è la definizione di Anno IPO?
L'offerta pubblica iniziale è un tipo di offerta pubblica in cui le azioni di una società di solito sono vendute a investitori istituzionali che, a loro volta, vendono al pubblico in generale, su una borsa valori, per la prima volta.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Anno IPO di aziende nel Health Care settore su NASDAQ rispetto a Accelerate Diagnostics Inc
Cosa fa Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Aziende con anno ipo simili a Accelerate Diagnostics Inc
- Shaw Communications ha Anno IPO di 1995
- Husky ha Anno IPO di 1995
- Transcontinental , Cl B Mv ha Anno IPO di 1995
- Mountain Inc ha Anno IPO di 1995
- Brookfield Asset Management ha Anno IPO di 1995
- ShawCor ha Anno IPO di 1995
- Accelerate Diagnostics Inc ha Anno IPO di 1996
- BXP ha Anno IPO di 1997
- Faro Technologies ha Anno IPO di 1997
- Silgan ha Anno IPO di 1997
- Warrior Gold ha Anno IPO di 1997
- Ryanair Plc ha Anno IPO di 1997
- SIGA Technologies Inc ha Anno IPO di 1997